Business Model Canvas: TEX44-Based Male Infertility Diagnostic Panel
A targeted genetic screening test for patients with asthenozoospermia to identify biallelic TEX44 variants and associated mitochondrial sheath defects. The panel aims to differentiate metabolic mitochondrial failures from other structural axonemal defects.
The Business Model Canvas reveals a high-specialization niche diagnostic tool that bridges the gap between generic motility tests and expensive whole-exome sequencing. While it offers high clinical value for metabolic differentiation, its success depends on integration into a broader panel to mitigate the risk of false negatives caused by genetic heterogeneity (e.g., LRRC6 mutations).
Key Partners3
Key Activities3
Key Resources3
Value Propositions3
Customer Relationships2
Channels3
Customer Segments2
Cost Structure3
Revenue Streams2
Necessary to define how the test is delivered to reproductive endocrinologists and how value is captured from fertility clinics. · Generated 2026-08-04 by cavi/gemma4-31b-it-awq-4bit-32kAI-generated